NCT00697996View on ClinicalTrials.gov

Rituximab for Pediatric Renal Transplant Rejection

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

August 31, 2007

Conditions
Kidney Transplantation
Interventions
DRUG

Rituximab for transplant rejection

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

Genentech and Biogen IDEC

UNKNOWN

lead

Stanford University

OTHER

NCT00697996 - Rituximab for Pediatric Renal Transplant Rejection | Biotech Hunter | Biotech Hunter